Allison C. Greene
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Allison C. Greene has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Wellington K. Hsu
Department of Orthopaedic Surgery, Northwestern University, Chicago, IL, 60611, United States
4 shared publications- Erin L. Hsu
Department of Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
3 shared publications - Abhishek S. Kannan
Orlando Health Jewett Orthopedic Institute Orlando Florida U.S.A.
2 shared publications - Chawon Yun
Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea
2 shared publications - David J. Ellenbogen
Section of Orthopaedic Surgery, Henry Ford Providence Hospital, Southfield, Michigan, USA
2 shared publications - Mark A. Plantz
Department of Orthopaedic Surgery Northwestern University Chicago Illinois USA
2 shared publications
Latest Publications
- 17 October 2023
- Published by Elsevier in Biomaterials
- Vol. 302, 122357
A supramolecular polymer-collagen microparticle slurry for bone regeneration with minimal growth factor
- 17 October 2023
- Published by Elsevier in Biomaterials
- Vol. 302, 122357
A supramolecular polymer-collagen microparticle slurry for bone regeneration with minimal growth factor
- 25 June 2022
- Published by Springer Nature
- p. 493-503
Surgical Management of Metastatic Disease to the Upper Extremity
- 25 June 2022
- Published by Springer Nature
- p. 493-503
Surgical Management of Metastatic Disease to the Upper Extremity
- Open Access
The effect of local steroid application on bony fusion in a rat posterolateral spinal arthrodesis model
Introduction: Local steroid administration during anterior cervical spine surgery has been shown to improve postoperative dysphagia. However, concerns over potential complications remain. This study aims to evaluate the effect of local steroid administration on bone regeneration and spine fusion in a preclinical model, as well as the impact on osteogenic differentiation of human bone marrow‐derived mesenchymal stem cells (hBM‐MSCs) in a 3D culture system.Materials and methods: Forty‐five rats underwent bilateral L4‐L5 posterolateral lumbar fusion (PLF) utilizing local delivery of low‐dose recombinant human bone morphogenetic protein‐2 (rhBMP‐2; 0.5 μg/implant). Rats were divided into three groups: no steroid (control), low dose (0.5 mg/kg), and high dose (2.5 mg/kg) of triamcinolone. Bone growth and fusion were assessed using radiography, blinded manual palpation, and micro‐CT analysis and were visualized by histology. The impact of triamcinolone exposure on osteogenic differentiation of hBM‐MSCs was evaluated by gene expression analysis, alkaline phosphatase activity assay, and alizarin red staining.Results: No significant differences in fusion scores or rates were seen in the low‐ or high‐dose steroid treatment groups relative to untreated controls. Quantification of new bone formation via micro‐CT imaging revealed no significant between‐group differences in the volume of newly regenerated bone. Triamcinolone also had no negative impact on pro‐osteogenic gene transcript levels, and ALP activity was enhanced in the presence of triamcinolone. Mineral deposition appeared comparable in cultures grown with and without triamcinolone.Conclusions: Local steroid application does not seem to inhibit rhBMP‐2‐mediated spine fusion in rats, though our study may not be adequately powered to detect differences in fusion as measured by manual palpation or bone volume as measured by micro‐CT. These findings suggest that local triamcinolone may not increase pseudarthrosis in spine fusion procedures. Further large animal and clinical studies to verify its safety and efficacy are warranted.
Open AccessThe effect of local steroid application on bony fusion in a rat posterolateral spinal arthrodesis model
Introduction: Local steroid administration during anterior cervical spine surgery has been shown to improve postoperative dysphagia. However, concerns over potential complications remain. This study aims to evaluate the effect of local steroid administration on bone regeneration and spine fusion in a preclinical model, as well as the impact on osteogenic differentiation of human bone marrow‐derived mesenchymal stem cells (hBM‐MSCs) in a 3D culture system.Materials and methods: Forty‐five rats underwent bilateral L4‐L5 posterolateral lumbar fusion (PLF) utilizing local delivery of low‐dose recombinant human bone morphogenetic protein‐2 (rhBMP‐2; 0.5 μg/implant). Rats were divided into three groups: no steroid (control), low dose (0.5 mg/kg), and high dose (2.5 mg/kg) of triamcinolone. Bone growth and fusion were assessed using radiography, blinded manual palpation, and micro‐CT analysis and were visualized by histology. The impact of triamcinolone exposure on osteogenic differentiation of hBM‐MSCs was evaluated by gene expression analysis, alkaline phosphatase activity assay, and alizarin red staining.Results: No significant differences in fusion scores or rates were seen in the low‐ or high‐dose steroid treatment groups relative to untreated controls. Quantification of new bone formation via micro‐CT imaging revealed no significant between‐group differences in the volume of newly regenerated bone. Triamcinolone also had no negative impact on pro‐osteogenic gene transcript levels, and ALP activity was enhanced in the presence of triamcinolone. Mineral deposition appeared comparable in cultures grown with and without triamcinolone.Conclusions: Local steroid application does not seem to inhibit rhBMP‐2‐mediated spine fusion in rats, though our study may not be adequately powered to detect differences in fusion as measured by manual palpation or bone volume as measured by micro‐CT. These findings suggest that local triamcinolone may not increase pseudarthrosis in spine fusion procedures. Further large animal and clinical studies to verify its safety and efficacy are warranted.
- 1 June 2021
- Published by Elsevier in Acta Biomaterialia
- Vol. 127, 146-158
Osteoinductivity and biomechanical assessment of a 3D printed demineralized bone matrix-ceramic composite in a rat spine fusion model
- 1 June 2021
- Published by Elsevier in Acta Biomaterialia
- Vol. 127, 146-158
Osteoinductivity and biomechanical assessment of a 3D printed demineralized bone matrix-ceramic composite in a rat spine fusion model
- 1 July 2020
- Published by SAGE Publications in HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery
- Vol. 16 (2) , 108-112
Technologies to Enhance Spinal Fusion: Bench to Bedside
- 1 July 2020
- Published by SAGE Publications in HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery
- Vol. 16 (2) , 108-112
Technologies to Enhance Spinal Fusion: Bench to Bedside
- 1 June 2019
- Published by AME Publishing Company in Journal of Spine Surgery
- Vol. 5 (S1) , S11-S18
Orthobiologics in minimally invasive lumbar fusion
Minimally invasive (MI) spine surgery continues to gain popularity with patients and surgeons for its potential to decrease operative time and avoid complications commonly associated with open surgery. In the face of a changing surgical landscape, selecting the appropriate implant material to be used in MI lumbar fusion procedures will remain critically important. Various orthobiologic materials are available for use, including autologous and allogeneic bone graft, bone marrow aspirate (BMA), demineralized bone matrix (DBM), ceramics, and growth factors. The purpose of this review is to summarize the use and efficacy of currently available products, as well as highlight the development of novel therapeutic options.
- 1 June 2019
- Published by AME Publishing Company in Journal of Spine Surgery
- Vol. 5 (S1) , S11-S18
Orthobiologics in minimally invasive lumbar fusion
Minimally invasive (MI) spine surgery continues to gain popularity with patients and surgeons for its potential to decrease operative time and avoid complications commonly associated with open surgery. In the face of a changing surgical landscape, selecting the appropriate implant material to be used in MI lumbar fusion procedures will remain critically important. Various orthobiologic materials are available for use, including autologous and allogeneic bone graft, bone marrow aspirate (BMA), demineralized bone matrix (DBM), ceramics, and growth factors. The purpose of this review is to summarize the use and efficacy of currently available products, as well as highlight the development of novel therapeutic options.